High-alert medications are drugs that bear a heightened risk of causing significant patient harm when they are used in error. Although mistakes may or may not be more common with these …
2024年1月11日 · High-alert medications are an essential component of drug therapy. However, while errors with these products are not necessarily more common, the consequences are …
ISMP publishes 2024 high-alert medication list
2024年2月3日 · The US Institute for Safe Medication Practices (ISMP) has published the 2024 version of its high-alert medication list, which includes input from safety experts and a national …
High-Alert Medication List Is Effective When Combined With Risk ...
2022年3月17日 · High-alert medications are drugs that carry a heightened risk of causing significant patient harm when they are used in error. Although mistakes may or may not be …
High-Alert Medications - MPR
2014年10月21日 · High-alert medications are drugs that bear a heightened risk of causing significant patient harm when they are used in error. Although mistakes may or may not be …
High-Alert Medications - VHA National Center for Patient Safety
2023年11月29日 · NCPS promotes three principles to improve high-alert medication administration and distribution: Eliminate the Possibility of Error. Reduce the number of drugs …
High-Alert Medications - ISMP Canada
High-alert medications are medications that bear a heightened risk of causing significant harm when they are used in error. This list is intended to assist care organizations in developing …
High-alert medications are drugs that bear a heightened risk of causing significant patient harm when they are used in error. Although mistakes may or may not be more...
High-Alert Medications in Acute Care Settings - ECRI and ISMP
2024年1月10日 · High-alert medications are drugs that bear a heightened risk of causing significant patient harm when they are used in error. Although mistakes may or may not be …
- 评论数: 5
ISMP's List of High-Alert Medications in Acute Care Settings.
2024年1月14日 · This fact sheet lists medications with a high risk of causing significant harm to patients when incorrectly administered. The 2024 publication reflects insights gathered …